Keep up-to-date with BioLineRx's company announcements by visiting the press release archive.
|Date||Title and Summary|
|Toggle Summary08/06/19||BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update|
|Toggle Summary05/14/19||BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update|
|Toggle Summary05/07/19||BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors|
|Toggle Summary03/28/19||BioLineRx Reports Year End 2018 Financial Results and Provides Corporate Update|
|Toggle Summary03/27/19||BioLineRx Announces Successful Engraftment Data from Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients|
|Toggle Summary02/04/19||BioLineRx Receives Orphan Drug Designation from the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer|